CSF1R and Parkinson disease: In conclusion, these data suggest that using [11C]CPPC as a radioligand of CSF1R can detect microgliosis in early PD with at least moderate severity in patients, and that variance in [11C]CPPC binding within patients with PD correlates with disability from motor dysfunction and cognitive impairment.